OBJECTIVE: To evaluate the quality of life (QoL), health-care resource utilization, and cost for the patients with premature ventricular contractions (PVCs) by radiofrequency catheter ablation (RFCA). METHODS: RFCA was performed in 58 patients with symptomatic PVCs that were refractory/easy to medication. A 24-hour ambulatory electrocardiographic monitoring, QoL, health-care resources utilization, and cost were assessed at a screening visit and 3 and 12 months after RFCA. RESULTS: RFCA was successfully performed in 56 patients (96.6%). This resulted in a significant improvement in the QoL at 3 and 12 months after the procedure. There were no major complications related to the procedure. Nine patients (15.5%) had residual arrhythmia. Seven of them underwent repeated ablation with successful results. It also improved the QoL and reduced health-care resource utilization and cost. CONCLUSIONS: RFCA is a safe and effective treatment for PVCs, and it is a viable alternative to drugs in the presence of disabling symptoms.
OBJECTIVE: To evaluate the quality of life (QoL), health-care resource utilization, and cost for the patients with premature ventricular contractions (PVCs) by radiofrequency catheter ablation (RFCA). METHODS: RFCA was performed in 58 patients with symptomatic PVCs that were refractory/easy to medication. A 24-hour ambulatory electrocardiographic monitoring, QoL, health-care resources utilization, and cost were assessed at a screening visit and 3 and 12 months after RFCA. RESULTS: RFCA was successfully performed in 56 patients (96.6%). This resulted in a significant improvement in the QoL at 3 and 12 months after the procedure. There were no major complications related to the procedure. Nine patients (15.5%) had residual arrhythmia. Seven of them underwent repeated ablation with successful results. It also improved the QoL and reduced health-care resource utilization and cost. CONCLUSIONS: RFCA is a safe and effective treatment for PVCs, and it is a viable alternative to drugs in the presence of disabling symptoms.
Authors: Li Jia; Li Yue-Chun; Ji Kang-Ting; Zhou Na-Dan; Lin Jia-Xuan; Zhang Wen-Wu; Yang Peng-Lin; Tang Ji-Fei; Lin Jia-Feng Journal: BMC Cardiovasc Disord Date: 2011-06-02 Impact factor: 2.298
Authors: Li Yue-Chun; Zhang Wen-Wu; Zhou Na-Dan; Zhang Teng; Wang Pin-Xiao; Ge Bei; Li Jia; Ji Kang-Ting; Lin Jia-Feng Journal: BMC Cardiovasc Disord Date: 2012-07-10 Impact factor: 2.298
Authors: Chien-Lung Chan; Ai-Hsien Adams Li; Hsiang-An Chung; Dinh-Van Phan Journal: Int J Environ Res Public Health Date: 2020-03-30 Impact factor: 3.390